Expression of the lysozyme gene is a marker for the differentiation of macrophages, lysozyme transcription being gradually increased during maturation. We have analyzed the fine structure and function of two macrophage-specific enhancer elements of the chicken lysozyme gene (E-2.7 kb and E-0.2 kb). Both increase their activities upon LPS induction, both contain multiple binding sites for similar or identical nuclear factors and both can be divided into two functional modules. For the E-0.2 kb enhancer we found a synergistic activity of the modules to be dependent on their distance. Binding sites for nuclear proteins within enhancer E-0.2kb overlap substantially with the previously identified progesterone/glucocorticoid receptor binding site, which is required for steroid induction of lysozyme transcription in the oviduct.
INTRODUCTION
One of the main contemporary challenges in molecular genetics is the elucidation of the mechanisms underlying tissue specific gene expression. Several tissue specific promoter and enhancer elements have been identified (1) . Many of the model systems analyzed are limited in that only mature cells or tissues are available for testing, whereas gene regulation may involve a multi step process during differentiation from precursor to mature cells. The haematopoetic cell population is generated by one of the few differentation pathways which can be studied step by step in vitro as well as in vivo. One of the cell types generated in this system is the macrophage cell. Expression of the lysozyme gene is a specific differentiation marker, being gradually turned on during maturation of macrophages (2) . In addition to this constitutive macrophage expression, the chicken lysozyme gene is inducible by steroid hormones in the tubular gland cells of the oviduct (3) .
Three macrophage-specific enhancer elements of the chicken lysozyme gene have been identified, one each at -6.1 kb (4), -2.7 kb (5) and -0.2 kb (5) upstream of the transcription start site. The latter two elements are referred to here using the abbreviated forms E-2.7 kb and E-0.2 kb according to their positions. Furthermore, two silencer elements which are specifically inactive in mature macrophages (S-2.4 kb and S-0.25 kb), and one which is active in all cell types tested (S-1.0 kb) have been described (5, 6) . Steroid induced expression in the oviduct is mediated by at least two different hormone responsive elements, one at -200 bp (7) and one at -1.9 kb (8) .
Here we report the fine structure of the two macrophage specific enhancer elements E-2.7 kb and E-0.2 kb, their functional activity and their capacity to bind nuclear proteins. The binding pattern in the multifunctional enhancer E-0.2 kb, which also contains functional steroid receptor binding sites (7) 
MATERIALS AND METHODS Plasmid Constructions
The identity of the recombinant plasmids was confirmed by restriction mapping and dideoxysequencing using the Sequenase-kit from USB.
The plasmids pICfrag21 and pUClys-280/+15 were created by inserting the HindIHI/BglIH-lysozyme gene fragment from -2.71 kb to -2.54 kb and the HindIHI/XhoIfragment carrying the lysozyme-promoter (-280 to + 15) from plysCATA -280 (5) into the corresponding sites in the polylinker of pIC20R (9) .
Two series of different plasmids containing subregions of lys E-0.2 kb were used, all of which are derivatives of the plamids pBLCAT2 (10) or plys-208/-67a tkCAT (5 (10) . Selected lysozyme sequences were inserted in antisense direction in front of the tk-promoter to test them directly for enhancercharacteristics.
pE-0.2-1 was generated by ligating the lysozyme BamHI/AccI fragment from pUC lys -208/-95 into the BamHI site of pBLCAT2. pE-0.2 -2 contains the lysozyme sequences from -208 to -162 as an RsaI/BamHIfragment cloned into the BamHI and filled-in Sall sites of pBLCAT2.
By cloning a blunt-ended HindIII/RsaI-fragment from pUClys -208/-67 harboring the region from -161 to -67 into the filled in BamHI-or HindIII-site of pBLCAT2 or the BamHI-site of pE-0.2 -2, we obtained the plasmids pE-0.2-3, -4, -5, -6 and -2 x 3. For a double insertion of the distal domain of E-0.2 kb this sequence was cut out of pE-0.2 -2 with BamHI and Hindu, filled in and re-inserted into the blunt-ended HindIll site of the same plasmid (pE-0.2-2x2).
For pSVtkCAT and E-2.7 constructions see Steiner et al., 1987 (5) . Nuclear Extract Preparation The nuclear extracts were prepared as described (11) (12) (13) . Subconfluent cells were harvested from about 60 culture dishes (15 cm in diameter) and washed in phosphate buffered saline. All following manipulations were performed at 0°C using precooled solutions, tubes and Figure 1 . DNaseI protection assay on the E-2.7 kb (A) and the E-0.2 kb enhancer (B). The upper (upper) and lower strands (lower) were 3' end-labelled and digested with DNaseI in the presence of HD1I nuclear extract (+) or without nuclear extract (-) . The 0.5 mM DTT) the nuclei were pelleted by centrifugation (2400 rpm; 10 min). This pellet was used to prepare the nuclear extract as described (12) with the modification that the volume of nuclear lysis buffer was 1 PCV and that the precipitated nuclear proteins were dissolved in 1/10 PCV of the dialysis buffer. The opaque nuclear extract with a protein concentration of 5-20 mg/ml (Biorad protein assay) was frozen in small aliquots in liquid nitrogen and stored at -85°C. DNaseI-Footprinting and Band Shift Assays To obtain probes labelled on one strand the plasmids pICfrag2l and pUClys -280/+15 were cut with EcoRI and labelled as described (14) . The footprint reactions were performed according to Cereghini et al., 1987 (15) with the described modifications (14) . (19) cells were maintained in DME-medium (Biochrom) supplemented with 8% fetal calf serum, 2% chicken serum, 100 units/ml penicillin and 100 jig/ml streptomycin. All transfection experiments were done in triplicate and confirmed in a second series of tests. Transfections were carried out as described (5) with the help of an automated 'precipitator' (20) . LPS treatment of HD1 1 cells was done by applying 0.1 tg/ml LPS to the dishes at 22hrs after transfer. All cells were harvested 2d after DNA transfer and assayed for CAT activity or for mRNA amounts (5). (5) Nucleic Acids Research (figure 2). Although differences in binding efficiences are seen-each oligonucleotide showing the best competition for the footprint on its corresponding region-it is obvious that all the 'core'-containing sequences show qualitatively identical competitor function in comparison to footprints which are not changed, such as the footprint upstream of -217 bp ( figure 2C ), which lies within the silencer element S-0.25 kb (6) and the E-2.7 kb footprints outside the 'core' sequence-containing region (E-2.7 kb sequences -2600 bp to -2700 bp; figure 2A) . One of the footprint regions (sequences -90 to -74 ) in the E-0.2 kb enhancer could only be detected quite weakly, and since the sequence resembles a Spl binding site (see figure 6 ), we performed band shift experiments with lysozyme DNA -96/-66 (figure 3). One major shifted band can be seen in addition to several minor bands. All can be competed specifically by the lysozyme sequence ( The extended footprint seen in the region -193 bp to -180 bp with the DU249 extract was also seen with an extract from another lysozyme negative cell line, HD3 erythroblasts (Baniahmad, Steiner and Renkawitz, unpublished results). This footprint may be the result of a single additional binding protein absent in HD1 1, or may reflect the binding of a completely different set of binding proteins in each extract. To distinguish between these two possibilities, we carried out footprinting reactions with the liver cell extract in the presence of an excess of various competitor oligonucleotides (figure 5). As a control we used the oligonucleotide -208/-162 (oligonucleotide 1, see figure 2 ) which covers the liver cell-specific footprint plus both flanking footprints. Upon competition this complete Figure 6 . Regions of the E-2.7 kb and the E-0.2 kb enhancer bound by nuclear proteins. Binding sequences as determined by footprinting and band shift experiments are boxed. DNA regions covered by the progesterone (PR) or glucocorticoid (GR) receptors are indicated (1, 22 (23) . This particular binding site has only a low affinity for GCN4 (24) , but since it is repeated, both may function in a synergistic manner. E-2.7F2 is quite similar to the SV40 PU-box, which can be bound by a lymphoid specific protein (25) . E-2.7F3 contains a strong binding sequence for GCN4-AP1 (24) . Sequences in E-2.7F4, E-0.2F4 and F5 are similar to each other (lys.cons.) (5) and to the 'core' enhancer sequence (21) . This motif can be bound by the AP3 protein (26, 27) or by C/EBP (28) . In addition E-0.2F4 is similar to a 'half binding site' of NFl (15) . E-2.7F5 shows similarities to AP3-C/EBP and to the 'octa'-sequence (29, 30) . AP3-C/EBP similaritiy is also seen with the footprint sequences E-0.2F1 and F3 with F3 containing a CAAT-box, which is bound by C/EBP as well (31) . All of the footprint sequences with AP3-C/EBP similarity are competeable by the SV40 'core'-sequence (see above) which is recognized by AP3 (27) . The footprint E-0.2F2 contains a sequence identical to the negative NRDI region of the human 13-interferon gene (32) figure 8A ). The recombined enhancer with both halves arranged in a head to head orientation (construct 0.2-4) maintained wildtype enhancer activity and tissue specificity. Upon separation of the two halves by 23 bp with the distal domain in sense orientation (construct 0.2-5) or by 46 bp with the distal domain in anti-sense orientation (construct 0.2-6) enhancer activity was considerably reduced.
In order to confirm that the observed CAT-activities reflect the amount of correctly initiated RNA, RNase mapping experiments were carried out on RNA generated after transfecting selected constructs in HD1 1 cells. These experiments confirmed the results of the CAT-assays (figure 8B).
To examine in more detail the observed disruption of enhancer activity following separation of the enhancer halves, we inserted linkers of different length (5, 8, 10, 13, 15, 17 and 20 bp) between positions -161 bp and -162 bp. CAT-activities recorded after transfection into HD1 1 cells are shown in figure 9 . Insertion of 5 bp reduced enhancer activity considerably, with a further reduction caused by an 8 bp spacer. However, a spacer of 10 bp leads to an increase in enhancer activity, presumably allowing the proteins bound to the two enhancer halves to be positioned in a three dimensional arrangement similar to that in the wildtype enhancer. This result indicates the requirement for a certain distance of the enhancer domains in order to function optimally. Further ,.
-) 60 1. I., %NW Nucleic Acids Research resulted in levels which, although suggestive of a periodicity in activities, lie within the deviation of the experiment.
We conclude that activity of the 150 bp E-0.2 kb enhancer is a result of a synergistic, orientation independent interaction between domains A and B, and that tissue specificity is achieved by the combinatorial effect of both domains. Both Enhancer are LPS Inducible Since lysozyme expression is gradually increased during macrophage differentiation (2) and since both enhancer elements show a higher activity in primary mature macrophages as compared to HD1 1 promacrophages (5) we analyzed the enhancer activity in LPS treated HD 11 cells. LPS is known to activate and to induce developmental changes in macrophages [for review see (35) ]. To test, whether the activity of the lysozyme enhancer elements is sensitive to LPS treatment of the cells, we carried out DNA transfer experiments in the presence of LPS. Transient expression of pE-0.2 tk CAT and pE-2.7 tk CAT in HD 1I cells was clearly induced by LPS, whereas the ptkCAT control plasmid was not induced (figure 10).
DISCUSSION
The complex regulation of the chicken lysozyme gene by steroid hormones in the oviduct and by the maturation of macrophages is achieved by the combined action of several enhancer, silencer and steroid responsive elements [for review see (36) ]. Whether all of these elements act independently on the promoter or whether they interact with each other remains to be shown. Here we describe the detailed analysis of both lysozyme geneenhancers E-2.7 kb and E-0.2 kb, which consist of several protein binding sites coinciding with functional modules. Some of the binding proteins are tissue-specific, others are present in liver cells as well as in promacrophages. Such a concomitant binding of cell-type specific and ubiquitous factors is also found in other enhancer elements, for example in that of the mouse cl-antitrypsin gene (37) . The lysozyme enhancers E-2.7 kb and E-0.2 kb together contain six 'core' motif homologies which are completely protected by nuclear proteins from digestion with DNaseI ( figure 6 ). Competition experiments demonstrate the importance of the 'core' homology in the binding, as cross-competition is a property of all protected regions which share only these sequences. This indicates that proteins with at least similar DNA-binding domains recognize different parts of both enhancers E-2.7 kb and E-0.2 kb. Although we find multiple similar binding sites, the enhancer domains show different activities, and specificities and therefore the binding proteins may be different. It is possible that the binding proteins described here are related to the previously characterised factors AP3 or C/EBP (26, 28) , although this has to be proven by analyzing the respective close contact sites on the recognition sequences. A similar puzzling situation of cell type specific and unspecific effects caused by the same binding sequence has been found for the octamer sequence [for review see (38) ]. Both rearranged modules. Investigation of the requirement for a particular distance of the two domains indicated a dependence of enhancer activity on the relative position of the modules. Similar effects of the stereospecific alignment on the efficiency of transcription regulating elements has been shown for the SV 40 enhancer (39) or for the interaction of the glucocorticoid receptor and the CACCC-protein (14) . In each case optimal activity was only observed after introduction of multiples of a complete helical turn of the DNA between the protein binding sites. In the case of lys E-0.2 kb, we observe a strong decrease of activity upon introducing additional nucleotides between its two domains with a peak of increased activity upon insertion of 10 bp. A synergistic interaction of the bound proteins in this constellation would be indicative of a bending of DNA between the two domains, a flexible protein domain and/or the involvement of a 'bridging protein' that mediates the interaction of the DNA-bound factors and could confer the flexibility to the whole system. Participation of non-DNA-binding proteins in transcription regulation has been shown in some cases (40) (41) (42) (43) (44) .
Domain structures such as those described here are also found in other transcription regulatory elements and seem to be a general phenomenon (37, 45, 46) . A modular structure may be adapted during evolution to a variety of regulatory processes by using various combinations of a limited number of different binding sites.
Clear tissue-specific differences in the binding pattern of liver cell and promacrophage Figure 10 . LPS induces enhancer activity. Both enhancer constructs pE-0.2 tk CAT (E-0.2) and pE-2.7 tk CAT (E-2.7) were transfected into LPS treated or untreated HD1 1 promacrophages. CAT activities are compared to the expression at ptk CAT (tk). and 8). Whether the increase of enhancer activity during differentiation or during LPS treatment involves one or several of these binding proteins remains to be shown. In the case of E-0.2 kb it seems that liver cells contain an extra DNA binding protein in addition to those found in the promacrophage line. A possible negative effect of this protein is also suggested by the remarkable similarity of the binding sequence with the negative regulatory domain I (NRDI) of the human fl-interaction gene (32) .
The E-0.2 kb enhancer of the chicken lysozyme gene can also bind steroid-hormonereceptors in vitro, and is involved in the hormonal control of lysozyme synthesis in the oviduct [(7) and figure 6 ]. Since the receptor binding sites are overlapping with the nuclear factor binding sites described in this paper, a degree of interference between regulatory proteins may be postulated, possibly involving a block of expression in the oviduct being overcome by a steroid stimulus. In other cells, although the appropriate receptors are present, nuclear factors might prevent binding of steroid receptors. Such a tissue specific steroid regulation has recently been demonstrated for the chicken ovalbumin gene (47) . The E-0.2 kb enhancer evidently acts as a multifunctional element: it contributes to the constitutive gene expression in macrophages and the hormone-induction in the oviduct, the regions mediating these effects being structurally, and probably functionally, highly integrated.
